Six in 10 Survivors of Moderate-to-Severe TBI Report Chronic Pain
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 10, 2024 -- Chronic pain impacts approximately 60 percent of survivors of moderate-to-severe traumatic brain injury (TBI), according to a study published in the January/February issue of The Journal of Head Trauma Rehabilitation.
Cynthia Harrison-Felix, Ph.D., from Craig Hospital in Englewood, Colorado, and colleagues estimated the prevalence of chronic pain after TBI and identified factors associated with chronic pain. The analysis included 3,804 participants who had been hospitalized with moderate-to-severe TBI.
The researchers found that 46 percent of participants reported current chronic pain, while 14 percent reported past (postinjury) chronic pain. There was little clinical difference in sociodemographic and injury characteristics between those reporting current, past, or no chronic pain. However, individuals with current chronic pain had worse functional outcomes versus individuals in the past pain or no pain groups. Current chronic pain was also associated with higher treatment utilization rates versus past pain.
"The implications of chronic pain for functional outcomes support inclusion of pain metrics in prognostic models and observational studies in this population," the authors write. "Future research is needed to proactively identify those at risk for the development of chronic pain and determine the efficacy and access to pain treatment."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-11 00:15
Read more
- Science Reveals Why Cancer Immunotherapies Can Sometimes Harm the Heart
- Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma
- ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
- Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina
- Risk for Psychiatric Disorders Up for Offspring of Moms With Eating Disorder
- Bidirectional Link Seen for Rheumatoid Arthritis, Interstitial Lung Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions